XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Stock-based Compensation Expense
The stock-based compensation related to our stock-based awards and employee stock purchase plan for the three months ended March 31, 2024 and 2023 is as follows (in thousands):
 Three Months Ended
March 31,
 20242023
Cost of net revenues$2,064 $1,807 
Selling, general and administrative28,494 28,691 
Research and development8,230 7,237 
Total stock-based compensation$38,788 $37,735 
Summary Of Restricted Stock Units A summary for the three months ended March 31, 2024 is as follows:
Number of Shares
Underlying RSUs
(in thousands)
Weighted Average Grant Date Fair ValueWeighted Average Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2023
736 $367.63 
Granted
610 311.35 
Vested and released(231)377.91 
Forfeited(20)377.56 
Unvested as of March 31, 2024
1,095 $333.90 2.0$359,130 
Summary Of Market-performance Based Restricted Stock Units
The following table summarizes the MSU performance activity for the three months ended March 31, 2024: 
Number of Shares
Underlying MSUs
(in thousands)
Weighted Average Grant Date Fair Value
Weighted Average
Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2023
158 $811.06 
Granted83 617.79 
Vested and released 1
(32)1,102.09 
Forfeited(5)1,102.09 
Unvested as of March 31, 2024
204 $679.52 2.1$66,889 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of the option component of the 2010 Purchase Plan shares was estimated at the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:
 Three Months Ended
March 31,
 20242023
Expected term (in years)0.91.8
Expected volatility56.0 %58.6 %
Risk-free interest rate4.8 %4.8 %
Expected dividends— — 
Weighted average fair value at grant date$100.10 $138.13